Medicina
DEPARTAMENTO
Hospital Universitario La Fe
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario La Fe (10)
2023
-
Changes in echocardiographic parameters over time in paradoxical low-flow low-gradient aortic stenosis
European heart journal. Cardiovascular Imaging, Vol. 24, Núm. 8, pp. 1120-1128
2022
-
Prognosis of Paradoxical Low-Flow Low-Gradient Aortic Stenosis: A Severe, Non-critical Form, With Surgical Treatment Benefits
Frontiers in Cardiovascular Medicine, Vol. 9
2020
-
Impact of 68Ga-PSMA PET/CT in the treatment of prostate cancer: Initial experience in Spain
Reports of Practical Oncology and Radiotherapy, Vol. 25, Núm. 3, pp. 405-411
2019
-
Prognosis of Patients With Severe Aortic Stenosis After the Decision to Perform an Intervention
Revista Española de Cardiología (English Edition), Vol. 72, Núm. 5, pp. 392-397
2016
-
Comparison of 1-Year Outcome in Patients with Severe Aorta Stenosis Treated Conservatively or by Aortic Valve Replacement or by Percutaneous Transcatheter Aortic Valve Implantation (Data from a Multicenter Spanish Registry)
American Journal of Cardiology, Vol. 118, Núm. 2, pp. 244-250
-
Cost Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccination Program in Chronic Obstructive Pulmonary Disease Patients Aged 50+ Years in Spain
Clinical Drug Investigation, Vol. 36, Núm. 1, pp. 41-53
2015
-
Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus
Clinical Infectious Diseases, Vol. 60, Núm. 6, pp. 950-958
2014
-
Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis
Journal of Acquired Immune Deficiency Syndromes, Vol. 66, Núm. 3, pp. 280-287
2011
-
Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus
Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 12, pp. 2843-2849
2002
-
Estudio epidemiológico retrospectivo sobre la duración del tratamiento de la infección por el virus de la inmunodeficiencia humana en España
Medicina Clinica, Vol. 119, Núm. 19, pp. 721-724